Breaking News

Bayer Invests $100M in Berkeley, CA Mfg. Site

Will build a product testing facility for next-gen hemophilia A treatments

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bayer HealthCare will invest $100 million in its Berkeley, CA manufacturing site to build a product testing facility that will support the next generation of treatments for hemophilia A.   “Building upon our legacy in hemophilia A, we are delighted to continue Bayer’s leadership in working to bring treatment options to patients around the world,” said Joerg Heidrich, senior vice president for Product Supply Biotech and site head at Bayer Berkeley.   “The new product testi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters